Research & Development Market Research Reports & Industry Analysis
New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce. In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.
Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.
Research & Development Industry Research & Market Reports
-
Focal Segmental Glomerulosclerosis (FSGS) - Market Insight, Epidemiology And Market Forecast - 2032
... and forecasted epidemiology as well as the market trends of focal segmental glomerulosclerosis (FSGS) in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The focal segmental glomerulosclerosis (FSGS) market report ... Read More
-
Global Biopharmaceutical CMO And CRO Market Size study, by Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars) and Regional Forecasts 2022-2028
... approximately USD 27.6 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.6 % over the forecast period 2022-2028. Biopharmaceutical CMO And CRO are contract manufacturing organizations and ... Read More
-
Global Psychedelic Drugs Market Size & Share to 2027
... Psilocybin, and Others) By Route of Administration (Oral, Injectable, and Inhalation), By Distribution Channel, By Region and Forecast till 2027 Global Psychedelic Drugs Market Psychedelic is called as psychedelics, which is class of hallucinogenic drugs ... Read More
-
Bacterial Vaginosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Bacterial Vaginosis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Ventilator Associated Pneumonia (VAP) Clinical trials scenario. This report provides top line data ... Read More
-
Pancreatitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Updateprovides an overview of Pancreatitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatitis. Report includes an ... Read More
-
Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Analysis Report By Service (Manufacturing, Research), By Region, And Segment Forecasts, 2022 - 2030
... The global pharmaceutical contract manufacturing and research services market size is expected to reach USD 395.2 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at ... Read More
-
Pharmaceutical Analytical Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 11,387.35 million by 2027, registering a CAGR of 8.20% from 2022 to 2027. While the sudden outbreak of the COVID-19 pandemic has negatively impacted most business sectors, the pharmaceutical analytical testing market has shown consistent ... Read More
-
Pharmaceutical Contract Manufacturing Organization (CMO) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... expected to reach USD 204.14 billion by 2027, registering a CAGR of 6.64% from 2022 to 2027. As a result of the rising demand for generic medicines and biologics, the capital-intensive nature of the business, ... Read More
-
Global Vaccine Growth Opportunities
... by emerging vaccine developers in designing novel technology platforms, especially for nucleic acid-based vaccines. Spurred by the ongoing pandemic, vaccine developers have accelerated the pace of transformation, and the concepts of manufacturing decentralization, digitization of ... Read More
-
Alzheimer’s Therapeutics Market
... a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the Alzheimer’s therapeutics market, the growth prospects of the market are obtained ... Read More
-
Vaccine Contract Manufacturing Market Report 2022-2032
... useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Factors Such As Reduced Market Time, Infrastructure Cost Benefits, And Operational Benefits Are Driving ... Read More
-
Central Lab Market (Product: Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services, Clinical Research & Trial Services, and Others; and End-user: Pharmaceutical Companies, Biotechnology Companies, and Academic & Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
... Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 Central Lab Market – Scope of Report TMR’s report on the global central lab market studies the past as well as the ... Read More
-
North America CBD Gummies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Category (Sugar-Free and Conventional) and Distribution Channel (Specialty Stores, Online Retail, and Others)
... expected to grow from US$ 1,984.1 million in 2021 to US$ 11,147.9 million by 2028; it is estimated to grow at a CAGR of 28.0% from 2021 to 2028. The popularity of CBD is increasing ... Read More
-
Leading Minor Cannabinoids Country Markets Databank
... 2029. Asia-Pacific is expected to be the highest contributor to this market, with $2,718.5 Million in 2020, and is anticipated to reach $5,888.3 Million by 2029, registering a CAGR of 9.01%. Asia-Pacific and North America ... Read More
-
Europe Minor Cannabinoids Market Databank
... Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid (CBGA) ... Read More
-
Global Senolytic Drugs Market, By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, Others), By Application (Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative Diseases, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition Forecast and Opportunities, 2017-2027
... Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition Forecast and Opportunities, 2017-2027 The global senolytic drugs market is expected to grow at a significant rate during the forecast period. The market growth can be attributed ... Read More
-
North America Minor Cannabinoids Market Databank
... 2029. Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid ... Read More
-
Asia-Pacific Minor Cannabinoids Market Databank
... Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid (CBGA) ... Read More
-
Cannabidiol (CBD) Market Size By Product (Oil, Tinctures, Suppository, Transdermal Patches, Isolates, Tablet, Capsules, Vape Oil, Creams And Roll-On, CBD Inhalers), By Application (Anxiety/Stress, Sleep/Insomnia, Chronic Pain, Migraine, Skin Care, Seizures, Joint Pain & Inflammation, Neurological Conditions), By Route of Administration (Oral, Topical, Inhalation, Transdermal Patches, Rectal, Sublingual), By Source (Marijuana, Hemp), By Distribution Channel (Online, Offline {Hospital Pharmacy, Retail Stores}), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Neurological Conditions), By Route of Administration (Oral, Topical, Inhalation, Transdermal Patches, Rectal, Sublingual), By Source (Marijuana, Hemp), By Distribution Channel (Online, Offline {Hospital Pharmacy, Retail Stores}), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, ... Read More
-
Global Minor Cannabinoids Market Databank
... Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid (CBGA) ... Read More
-
Leading Minor Cannabinoids Product Markets Databank
... 2029. Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid ... Read More
-
Leading Minor Cannabinoids Application Markets Databank
... 2029. Cancer segment is expected to be the highest contributor to this market, with $1,514.2 Million in 2020, and is anticipated to reach $2,883.6 Million by 2029, registering a CAGR of 7.47%. Pain Management segment ... Read More
-
Latin America, Middle East & Africa Minor Cannabinoids Market Databank
... 7.51% from 2021 to 2029. Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR ... Read More
-
Big Data in Pharmaceuticals - Thematic Research
... industries generate data in abundance from a multitude of sources including physician notes, pathology reports, electronic health records (EHR), patient registries, genomics, clinical trials, social media, wearable devices, and many more. The dataset in question ... Read More
Research Assistance
